In patients with prostate cancer, high expression levels of CX3CR1 were required for FGF9 to activate FGFR1 signaling (Figure 9D), and CX3CR1 was positively associated with FGFR1 activation under FGF9 secretion (Figure 9G). This evidence concerns the gene CX3CR1 and Familial prostate cancer.